Yesterday, Kymriah, a gene therapy made by Novartis that treats an aggressive type of leukemia was approved for children and young adults. The new commissioner of the FDA, Dr. Scott Gottlieb, remarked on the FDA's approval of the first gene therapy in the United States.
For our Duchenne community on the brink of starting gene therapy clinical trials, this news is another piece of evidence show…